Arch J R S, Newsholme E.A.1978Activities and some properties of 5'-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of concentration and the physiological role of adenosine. Biochem J174: 965-977
2.
Boulenger J.P., Uhde T.W., Wolff E.A., Post R.M.1984Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Arch Gen Psychiat41: 1067-1071
3.
Bowmer C.J., Yates M.S.1989Therapeutic potential for new selective adenosine receptor ligands and metabolism inhibitors. TiPS10: 339-342
4.
Bridges A.J., Moos H.W., Szotek D.L., Trivedi B.K., Bristol J.A., Heffner T.G., Bruns R.F., Downs D.A.1987N6-(2,2-diphenylethyl)-adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. J Med Chem30: 1709-1711
5.
Bruns R.F., Daly J.W., Snyder S.H.1980Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci USA77: 5547-5551
6.
Casas M., Ferre S., Guix T. Jane F1988Theophylline reverses haloperidol-induced catalepsy in the rat. Biol Psychiat24: 642-648
7.
Conners C.K.1979The acute effects of caffeine on evoked response, vigilance and activity levels of hyperkinetic children. J Abnorm Child Psychol7: 145-151
8.
Coffey C.E., Weiner R.D. Hinkle P E, Cress M., Daughtry G., Wilson W.H.1987Augmentation of ECT seizures with caffeine. Biol Psychiat22: 647-649
9.
Daly J.W., Padgett W., Shamim M.T.1986Analogues of caffeine and theophylline: effect of structural alerations on affinity at adenosine receptors. J Med Chem28: 487-492
10.
DeFreitas B., Schwartz G.1979Effects of caffeine in chronic psychiatric patients . Am J Psychiat136: 1337-1338
11.
Deckert J., Bisserbe J.C., Kline E., Marangos P.J.1988Adenosine uptake sites in brain: regional distribution of putative subtypes in relationship to adenosine A 1 receptors. J Neurosci8: 2338-2349
12.
Deckert J., Morgan P.F., Marangos P.J.1988. Adenosine uptake heterogeneity in the mammalian CNS? Uptake inhibitors as probes and potential neuropharmaceuticals. Life Sci42: 1331-1345
Deckert J., Verma A., Marangos P.J.1989[3H]DIpyridamole([3H]DPR) and [3H]nitrobenzylthioinosine ([3H]NBI) binding in human brain and erythrocytes. J Neurochem (Supplement 1 ) 74
15.
Dragunow M., Raull R L M1988Neuroprotective effects of adenosine. TiPS9: 193-194
16.
Fastbom J., Pazos A., Probst A., Palacios J.M.1987Adenosine A1 receptors in the human brain: a quantitative autoradiographic study. Neuroscience22: 827-839
17.
Ferkany J.M., Valentine H.Stone G., Williams M.1986Adenosine A1 receptors in mammalian brain: species differences in their interactions with agonists and antagonists. Drug Develop Res9: 85-93
18.
Fink M.1987New technology in convulsive therapy: a challenge in training . Am J Psychiat144: 1195-1198
Gerlach E., Becker B.F.1987Topics and perspectives in adenosine research. Springer, Berlin
21.
Ghai G., Francis J.E., Williams M., Dotson R.A., Hopkins M.F., Cote D.T., Goodman F.R., Zimmerman M.B.1987Pharmacological characterization of CGS 15943 A: a novel non-xanthine antagonist. J Pharmacol Exp Ther242: 784-790
22.
Gleiter C.H., Deckert J., Nutt D.J.1988Changes in caffeine seizure threshold after electroconvulsive shock. Psychopharmacology95: 544-545
23.
Gleiter C.H., Deckert J. Nutt D J, Marangos P.J.1989Electroconvulsive shock (ECS) and the adenosine neuromodulatory system. J Neurochem52: 641-646
24.
Goodman Gilman A, Goodman L S, Rall T W, Murad F (eds) 1985The pharmacological basis of therapeutics. Macmillan, New York
25.
Goodman R.R., Snyder S.H.1982Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine. J Neurosci2: 1230-1241
26.
Greden J.F.1981Caffeinism and caffeine withdrawal. In: Lowinson H J, Ruiz P (eds) Substance abuse. Clinical problems and perspectives. Williams and Wilkins, Baltimore, pp 274-286
27.
Hagberg H., Andersson P., Lazarewicz J., Jacobson I., Butcher S., Sandberg M.1987Extracellular adenosine, inosine, hypoxanthine and xanthine in relation to tissue nucleotides and purines in rat striatum during ischemia . J Neurochem49: 227-231
28.
Hare R.B.1968Sleep in the elderly. Can Med Assoc J98: 176
29.
Hindmarch I., Subhan Z.1985A preliminary investigation of Albert 285', HWA 285 on psychomotor performance, mood and memory. Drug Develop Res5: 379-385
30.
Ho A.D., Ganeshaguru K.1988Enzymes of purine metabolism in lymphoid neoplasms, clinical relevance for treatment with enzyme inhibitors. Klin Wochenschr66: 467-474
31.
Hoppenbrouwers M.L., VanDenBussche G.1989Mioflazine. a nucleoside transport inhibitor is effective as a sleep promotor in humans. In: Wauquier A.Dugovic C, Radulovacki M (eds) Slow wave sleep: physiological, pathophysiological and functional aspects. Raven Press , New York, pp 301-309.
Jarvis M., Schulz R., Hutchinson A.J., Do U.H., Sills M.A., Williams M.1989[3H]CGS 21 860, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brainJ Pharmacol Exp Ther251: 888-893
34.
Kolossa N., Pfleger K., Rummel W.1970Specificity of adenosine uptake into the heart and inhibition by dipyridamole. Europ J Pharmacol9: 265-268
35.
Lee K.S., Reddington M.19861,3-Dipropyl-8-cyclopentylxanthine (DPCPX) inhibition of [3H]N-ethylcarboxamidoadenosine (NECA) allows the visualization of putative non-A1 adenosine receptors. Brain Res368: 394-389
36.
Lee K.S., Schubert P., Reddington M. Kreutzberg G W 1986The distribution of adenosine A1 receptors and 5'nucleotidase in the hippocampal formation of several mammalian species. J Comp Neurol246: 427-434
37.
Lieberman H.R., Wurtman R.J., Emde G.G., Roberts C., Coviella I.L.1987The effects of low doses of caffeine on human performance and mood. Psychopharmacology92: 99-109
38.
Nagy J.I., La Bella L.A., Buss M., Daddona P.E.1984Immunohistochemistry of adenosine deaminase: implications for adenosine neurotransmission. Science224: 166-168
39.
Newby A.C.1984Adenosine and the concept of retaliatory metabolites . TiBS9: 42-44
40.
Paul B., Chen M.F., Paterson A R P1975Inhibitors of nucleoside transport. A structure-activity study using human erythrocytes. J Med Chem18: 968-972
41.
Pellow S., Chopin P., File S.E., Briley M.1985Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth14: 149-167
42.
Phillis J W, Edstrom J P, Kostopoulos G.K., Kirkpatrick J.R.1979Effects of adenosine and adenine nucleotides on synaptic transmission in the cerebral cortex. Can J Physiol Pharmacol57: 1289-1312
43.
Philips E., Newsholme E.A.1979Maximum activities, properties and distribution of 5'-nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain. J Neurochem33: 553-558
44.
Radulovacki M., Virus R.M., Djuricic-Nedelson M., Green R.D.1984Adenosine analogs and sleep in rats. J Pharmacol Exp Ther228: 268-274
45.
Reimann H.A.1967Caffeinism. J Am Med Assoc202: 1105-1106
46.
Schubert P., Lee K., West M., Deadwyler S., Lynch G.1976Stimulation-dependent release of [3H]-adenosine derivatives from central axon terminals to target neurons. Nature260: 541-542
47.
Silinsky E.M., Hubbard J.I.1973Release of ATP from rat motor nerve terminals. Nature243: 404-405
48.
Slapke J., Hummel S., Wilke A., Wenz W., Meister M., Förster R., Weisner B., Nussbücker B.1988Asthmatherapie mit Theophyllinpräparaten. Z Erkr Atmungsorgane170: 32-48
49.
Stone G.A., Jarvis M.F., Sillis M.A., Weeks B., Snowhill E.W., Williams M.1988Species differences in high affinity adenosine A2 receptor binding sites in striatal membranes from mammalian brain. Drug Develop Res15: 31-46
50.
Van Calker D, Müller M., Hamprecht B.1979Adenosine regulates, via two different types of receptors the accumulation of cyclicAMP in cultured brain cells. J Neurochem33: 999-1005
51.
Williams M.1987Purinergic receptors and central nervous system function . In: Meltzer H Y (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 284-301
52.
Williams M., Jarvis M.F.1988Adenosine antagonists as potential therapeutic agents . Pharmacol Biochem Behav29: 433-441
53.
Winsky L., Harvey J.A.1987Effects of N6-(L-phenylisopropyl)adenosine, caffeine, theophylline and rolipram on the acquisition of conditioned responses in the rabbit. J Pharmacol Exp Ther241: 223-229
54.
Wu P.H., Phillis J.W.1984Commentary: uptake by central nervous tissue as a mechanism for the regulation of extracellular adenosine concentrations. Neurochem Inter613-632
